Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCipla

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Sell SRF, Apollo Tyres; buy Cipla: Pritesh Mehta

      Pritesh Mehta of IIFL recommends selling SRF and Apollo Tyres and advises buying Cipla.

    • Book profits in Cipla, says Shahina Mukadam

      Shahina Mukadam, Market Expert is of the view that one may book profits in Cipla.

    • Buy Hindustan Unilever on declines: Mithil Pradhan

      Mithil Pradhan of Violet Arc Global Managers recommends buying Hindustan Unilever on declines.

    • Phani Sekhar positive on largecap pharma space

      Phani Sekhar, Fund Manager--PMS at Karvy Stock Broking has a positive view on largecap pharma space.

    • Hold Cipla, says Sharmila Joshi

      According to Sharmila Joshi of sharmilajoshi.com, one may stay invested in Cipla.

    • Sell Ashok Leyland, Cipla: Mithil Pradhan

      Mithil Pradhan of Violet Arc Global Managers recommends selling Ashok Leyland and Cipla.

    • Stay with Cipla, may hit Rs 675-680: Sameet Chavan

      Sameet Chavan of Angel Broking is of the view that above Rs 650, Cipla may hit Rs 675-680.

    • Go long in Cipla, advises Jai Bala

      Jai Bala of 1857 Advisors recommends going long in Cipla as the stock may test Rs 800.

    • Buy Cipla, target Rs 640: Chandan Taparia

      Chandan Taparia of Anand Rathi Securities recommends buying Cipla for a target of Rs 640.

    • Exit Cipla on bounce, says Hemen Kapadia

      Hemen Kapadia of KR Choksey Securities advises exiting Cipla.

    • Your stocks: Top chart picks by market experts

      Watch the interview of Hemen Kapadia of KR Choksey Securities who shared his readings and outlook on specific stocks and sector & Feroze Azeez of Anand Rathi Financial Svcs answered few personal finance queries.

    • Buy Cipla, target Rs 640 in 6-8 months: Daljeet Singh Kohli

      Daljeet Singh Kohli, head of research at India Nivesh Securites recommends buying Cipla for a target of Rs 640 in next 6-8 months.

    • Buy Cipla 600 Call: Chandan Taparia

      Chandan Taparia of Anand Rathi Securities is of the view that one can buy Cipla 600 Call.

    • Nandan Chakraborty overweight on pharma space

      Nandan Chakraborty of Axis Capital is overweight on pharma space.

    • Wockhardt in downtrend, looks weak: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Wockhardt is in a downtrend and looks weak.

    • Top buzzing midcap stocks to trade on June 9

      Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Vedanta, Cairn India, Bharat Forge, Havells, Sun TV, Nestle, Tata Steel, Cipla, Unitech & KEC.

    • Prefer Cadila Healthcare, Wockhardt: Sanju Verma

      Sanju Verma of Violet Arc Global Managers is of the view that one may prefer Cadila Healthcare followed by Wockhardt and Cipla.

    • Hold Cipla, says Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com advises holding Cipla with long term view.

    • Look at Cipla, says Meghana Malkan

      Meghana V Malkan of malkansview.com is of the view that one may look at Cipla.

    • Buy Asian Paints, LIC Housing; sell Cipla: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying Asian Paints and LIC Housing Finance and advises selling Cipla.

    • Invest in Cipla, says Niraj Dalal

      Niraj Dalal, founding partner at 3A Capital Advisors is of the view that Cipla is an investing opportunity.

    • Buy Cipla, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Cipla.

    • Buy Crompton Greaves, Cipla; sell IGL: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying Crompton Greaves and Cipla and advises selling Indraprastha Gas.

    • Prefer Lupin, Cipla: Sudarshan Sukhani

      According to Sudarshan Sukhani of s2analytics.com, among pharma stocks Lupin is the favourite and so is Cipla.

    • Hold Cipla, says Kunal Bothra

      Kunal Bothra of LKP Securities recommends holding Cipla.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347